Network origin in Robert Schiestl first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany.
9
| Holding Company | Pharmaceuticals: Other | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Schiestl via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
UroTiss GmbH
 UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | Medical/Nursing Services | Director of Finance/CFO | |
| PROPANC BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Bonn | College/University | Corporate Officer/Principal |
Statistics
International
| Germany | 3 |
| Australia | 2 |
Sectoral
| Health Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Most connected contacts
- Stock Market
- Insiders
- Robert Schiestl
- Company connections
